v3.26.1
Note 4 - Business Combination (Details Textual)
$ / shares in Units, $ in Thousands
8 Months Ended
Apr. 30, 2025
USD ($)
Rate
$ / shares
shares
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Finite-Lived Intangible Asset, Useful Life (Year)   6 years 11 months 4 days  
Goodwill   $ 5,175 $ 0
Trade Names [Member]      
Finite-Lived Intangible Asset, Useful Life (Year)   2 years 3 months 29 days  
Developed Technology Rights [Member]      
Finite-Lived Intangible Asset, Useful Life (Year)   8 years 3 months 29 days  
Noncompete Agreements [Member]      
Finite-Lived Intangible Asset, Useful Life (Year)   4 years 3 months 29 days  
Evoke Neuroscience, Inc. [Member]      
Payments to Acquire Businesses, Gross $ 3,000    
Business Combination, Consideration Transferred, Equity Interest $ 2,743    
Business Combination, Price Per Share (in dollars per share) | $ / shares $ 3.5    
Business Combination, Contingent Consideration, Liability $ 478    
Business Combination, Consideration Transferred $ 6,221    
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares (in shares) | shares 857,142    
Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount $ 500    
Goodwill $ 5,175    
Business Combination, Acquiree's Revenue since Acquisition Date, Actual   $ 946  
Business Combination, Acquiree's Earnings (Loss) since Acquisition Date, Actual   $ (157)  
Evoke Neuroscience, Inc. [Member] | Measurement Input, Discount Rate [Member]      
Business Combination, Contingent Consideration, Liability, Measurement Input | Rate 0.036    
Evoke Neuroscience, Inc. [Member] | Measurement Input, Discount Rate [Member] | Valuation Technique, Monte Carlo Pricing Model [Member]      
Business Combination, Contingent Consideration, Liability, Measurement Input | Rate 0.035    
Evoke Neuroscience, Inc. [Member] | Measurement Input, Assumed Income Tax Rate [Member]      
Business Combination, Contingent Consideration, Liability, Measurement Input | Rate 0.265    
Evoke Neuroscience, Inc. [Member] | Measurement Input, Assumed Income Tax Rate [Member] | Valuation Technique, Monte Carlo Pricing Model [Member]      
Business Combination, Contingent Consideration, Liability, Measurement Input | Rate 0.265    
Evoke Neuroscience, Inc. [Member] | Measurement Input, Price Volatility [Member]      
Business Combination, Contingent Consideration, Liability, Measurement Input | Rate 0.024    
Evoke Neuroscience, Inc. [Member] | Measurement Input, Price Volatility [Member] | Valuation Technique, Monte Carlo Pricing Model [Member]      
Business Combination, Contingent Consideration, Liability, Measurement Input | Rate 0.016    
Evoke Neuroscience, Inc. [Member] | Trade Names [Member]      
Finite-Lived Intangible Asset, Useful Life (Year) 3 years    
Evoke Neuroscience, Inc. [Member] | Developed Technology Rights [Member]      
Finite-Lived Intangible Asset, Useful Life (Year) 9 years    
Evoke Neuroscience, Inc. [Member] | Noncompete Agreements [Member]      
Finite-Lived Intangible Asset, Useful Life (Year) 5 years    
Evoke Neuroscience, Inc. [Member] | Noncompete Agreements [Member] | Measurement Input, Discount Rate [Member]      
Finite-Lived Intangible Assets, Measurement Input (Rate) | Rate 0.15    
Evoke Neuroscience, Inc. [Member] | Noncompete Agreements [Member] | Measurement Input, Royalty Rate [Member]      
Finite-Lived Intangible Assets, Measurement Input (Rate) | Rate 0.035    
Evoke Neuroscience, Inc. [Member] | Noncompete Agreements [Member] | Measurement Input, Assumed Income Tax Rate [Member]      
Finite-Lived Intangible Assets, Measurement Input (Rate) | Rate 0.265    
Evoke Neuroscience, Inc. [Member] | Earn Out Shares [Member]      
Business Combination, Contingent Consideration, Liability $ 500    
Business Combination, Contingent Consideration, Earnout Period (Year) 36 months